software metabo analyst 4.0 Search Results


nexera uhplc system  (Shimadzu Corporation)
99
Shimadzu Corporation nexera uhplc system
Nexera Uhplc System, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pm40010271-436-10-13?v=Shimadzu+Corporation
Average 99 stars, based on 1 article reviews
nexera uhplc system - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
high-fat diet  (ssniff Spezialdiaten)
90
ssniff Spezialdiaten high-fat diet
High Fat Diet, supplied by ssniff Spezialdiaten, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pm19756714-72-39-53?v=ssniff+Spezialdiaten
Average 90 stars, based on 1 article reviews
high-fat diet - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
proliferative metabolism  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology proliferative metabolism
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
Proliferative Metabolism, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pmc07503554-164-119-129?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
proliferative metabolism - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
13c [1-13c] pyruvic acid  (Cambridge Isotope Laboratories)
90
Cambridge Isotope Laboratories 13c [1-13c] pyruvic acid
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
13c [1 13c] Pyruvic Acid, supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pm30344111-360-0-10?v=Cambridge+Isotope+Laboratories
Average 90 stars, based on 1 article reviews
13c [1-13c] pyruvic acid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
40 mci/ml of [35s]cys/met mixture  (ICN Biomedicals)
90
ICN Biomedicals 40 mci/ml of [35s]cys/met mixture
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
40 Mci/Ml Of [35s]Cys/Met Mixture, supplied by ICN Biomedicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pm09083095-89-12-14?v=ICN+Biomedicals
Average 90 stars, based on 1 article reviews
40 mci/ml of [35s]cys/met mixture - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
c_30634242_40  (Thermo Fisher)
91
Thermo Fisher c_30634242_40
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
C 30634242 40, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pm37479763-86-15-17?v=Thermo+Fisher
Average 91 stars, based on 1 article reviews
c_30634242_40 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier
0.5% nonidet p-40  (ICN Biomedicals)
90
ICN Biomedicals 0.5% nonidet p-40
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
0.5% Nonidet P 40, supplied by ICN Biomedicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pmc02198974-15-8-10?v=ICN+Biomedicals
Average 90 stars, based on 1 article reviews
0.5% nonidet p-40 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
c33  (ATCC)
96
ATCC c33
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
C33, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/10__1128_slash_aac__00602___19-59-14-69?v=ATCC
Average 96 stars, based on 1 article reviews
c33 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
dextran coated charcoal 2 p r endocrinology 274 2007 19 29 dcc stripped fbs  (Thermo Fisher)
99
Thermo Fisher dextran coated charcoal 2 p r endocrinology 274 2007 19 29 dcc stripped fbs
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
Dextran Coated Charcoal 2 P R Endocrinology 274 2007 19 29 Dcc Stripped Fbs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pm17597290-52-14-29?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
dextran coated charcoal 2 p r endocrinology 274 2007 19 29 dcc stripped fbs - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
sodium 1 14 c acetate  (Revvity)
91
Revvity sodium 1 14 c acetate
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
Sodium 1 14 C Acetate, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pmc06289072-105-16-22?v=Revvity
Average 91 stars, based on 1 article reviews
sodium 1 14 c acetate - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier
admet descriptors  (Gilead Sciences)
99
Gilead Sciences admet descriptors
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
Admet Descriptors, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/10__3390_slash_molecules26092806-88-10-23?v=Gilead+Sciences
Average 99 stars, based on 1 article reviews
admet descriptors - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
portable metabolic rate monitor  (SUZUKEN CO LTD)
90
SUZUKEN CO LTD portable metabolic rate monitor
Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and <t>proliferative</t> <t>metabolism</t> (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.
Portable Metabolic Rate Monitor, supplied by SUZUKEN CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+metabo+analyst+4%2E0/pmc05111549-64-3-22?v=SUZUKEN+CO+LTD
Average 90 stars, based on 1 article reviews
portable metabolic rate monitor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and proliferative metabolism (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro

doi: 10.3390/ijms21175951

Figure Lengend Snippet: Overview on the molecular changes related to the resistance inducing mechanisms in C26 cells to DOX treatment under normoxia. Cropped Western blot images and their representative graphs displaying the percentage of protein levels after 24 h treatment with 0.3 µM DOX under normoxia compared to controls (the levels of the same proteins in untreated cell lysates) are shown for phosphatidylinositol-3 kinase (PI3K) in panel ( A ); for protein kinase B (Akt) in panel ( B ); for proto-oncogene tyrosine-protein kinase Src (c-Src) in panel ( C ); for the c-Jun subunit of AP-1 transcription factor (AP-1 c-Jun) in panel ( D ); for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in panel ( E ); for c-master regulator of cell cycle entry and proliferative metabolism (c-Myc) in panel ( F ); for B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL) in panel ( G ), for Bcl-2-associated X protein (BAX) in panel ( H ); and for hypoxia-inducible factor 1-alpha (HIF-1α) in panel ( I ). β-actin was used as loading control. Data were expressed mean ± SD of duplicate measurements from two independent experiments. Unpaired t -test was used for statistical analysis of the data; ns : not significant, p > 0.05; *, p < 0.05; **, p < 0.01, ***, p < 0.001.

Article Snippet: Membranes were incubated with primary antibodies overnight at 4 °C for p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65; mouse monoclonal IgG anti-mouse, 1:500 dilution, sc-56735, Santa Cruz Biotechnology, Santa Cruz, CA, USA), c-Jun subunit of activator protein 1 (AP-1 c-Jun; rabbit polyclonal IgG anti-mouse, 1:1000 dilution, sc-45, Santa Cruz Biotechnology), B-cell lymphoma–extra-large anti-apoptotic protein (Bcl-xL; rabbit monoclonal IgG anti-mouse, 1:500 dilution, 2764, Cell Signaling), phosphatidylinositol-3 kinase (PI3K; rabbit polyclonal IgG anti-mouse, 1:1000 dilution, 4292, Cell Signaling, Beverly, MA, USA), protein kinase B (Akt; rabbit monoclonal IgG anti-mouse, 1:1000 dilution, 4691, Cell Signaling), proto-oncogene tyrosine-protein kinase Src (c-Src; rabbit polyclonal IgG anti-mouse, 1:1000 dilution, sc-018, Santa Cruz Biotechnology), c-master regulator of cell cycle entry and proliferative metabolism (c-Myc; mouse monoclonal IgG anti-mouse, 1:500 dilution, sc-42, Santa Cruz Biotechnology), Bcl-2-associated X protein (BAX; rabbit polyclonal IgG anti-mouse, 1:500 dilution, 2772S, Cell Signalling), hypoxia-inducible factor 1-alpha (HIF-1α; rabbit polyclonal IgG anti-mouse, 1:500 dilution, ab17983, Abcam, Newcastle, UK), β-actin (rabbit polyclonal IgG anti-mouse, 1:1000 dilution, sc-130656, Santa Cruz Biotechnology), and HRP-labeled IgG goat anti-rabbit (sc-2004) or goat anti-mouse (sc-2005) secondary antibodies (1 h incubation, 1:2500 dilution, Santa Cruz Biotechnology).

Techniques: Western Blot, Control